VIAFUZE Trademark

Trademark Overview

On Tuesday, May 25, 2021, a trademark application was filed for VIAFUZE with the United States Patent and Trademark Office. The USPTO has given the VIAFUZE trademark a serial number of 90733706. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, February 11, 2025. This trademark is owned by Globus Medical, Inc.. The VIAFUZE trademark is filed in the Pharmaceutical Products category with the following description:

Implant material for use in orthopedic surgery primarily comprising allograft bone tissue
viafuze

General Information

Serial Number90733706
Word MarkVIAFUZE
Filing DateTuesday, May 25, 2021
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, February 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements

Goods and ServicesImplant material for use in orthopedic surgery primarily comprising allograft bone tissue

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlobus Medical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAudubon, PA 19403
Party NameGlobus Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAudubon, PA 19403

Trademark Events

Event DateEvent Description
Friday, September 10, 2021ASSIGNED TO EXAMINER
Friday, May 28, 2021NEW APPLICATION ENTERED
Friday, August 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 13, 2021SUSPENSION LETTER WRITTEN
Monday, September 13, 2021LETTER OF SUSPENSION E-MAILED
Monday, September 13, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 21, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, March 30, 2022SUSPENSION LETTER WRITTEN
Wednesday, March 30, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, March 30, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 21, 2022SUSPENSION LETTER WRITTEN
Friday, October 21, 2022LETTER OF SUSPENSION E-MAILED
Sunday, November 12, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, April 25, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, November 12, 2023SUSPENSION LETTER WRITTEN
Sunday, November 12, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, November 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 24, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Related Keywords

viafuze allograft bone tissue comprising primarily material orthopedic surgery implant